These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 16797553

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S, Krauze-Brzósko K, Manarini S, Evangelista V, Cerletti C.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):79-83. PubMed ID: 15044038
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
    Lee JJ, Yu JY, Lee JH, Zhang WY, Kim TJ, Myung CS, Yun YP.
    Arch Pharm Res; 2010 Mar 19; 33(3):387-94. PubMed ID: 20361303
    [Abstract] [Full Text] [Related]

  • 9. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR, Cho MR, Lee KS, Lee JJ, Lim Y, Han XH, Oh KW, Hong JT, Yoo HS, Yun YP.
    Basic Clin Pharmacol Toxicol; 2005 Sep 19; 97(3):162-7. PubMed ID: 16128910
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mechanism for antiplatelet effect of onion: AA release inhibition, thromboxane A(2)synthase inhibition and TXA(2)/PGH(2)receptor blockade.
    Moon CH, Jung YS, Kim MH, Lee SH, Baik EJ, Park SW.
    Prostaglandins Leukot Essent Fatty Acids; 2000 May 19; 62(5):277-83. PubMed ID: 10883058
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Metabolomic investigation of the anti-platelet aggregation activity of ginsenoside Rk₁ reveals attenuated 12-HETE production.
    Ju HK, Lee JG, Park MK, Park SJ, Lee CH, Park JH, Kwon SW.
    J Proteome Res; 2012 Oct 05; 11(10):4939-46. PubMed ID: 22873173
    [Abstract] [Full Text] [Related]

  • 16. Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
    Chang MC, Chang HH, Wang TM, Chan CP, Lin BR, Yeung SY, Yeh CY, Cheng RH, Jeng JH.
    PLoS One; 2014 Oct 05; 9(8):e104310. PubMed ID: 25122505
    [Abstract] [Full Text] [Related]

  • 17. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
    Khamrang T, Hung KC, Hsia CH, Hsieh CY, Velusamy M, Jayakumar T, Sheu JR.
    Int J Mol Sci; 2017 Apr 27; 18(5):. PubMed ID: 28448438
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bakkenolide G, a natural PAF-receptor antagonist.
    Liao CH, Ko FN, Wu TS, Teng CM.
    J Pharm Pharmacol; 1997 Dec 27; 49(12):1248-53. PubMed ID: 9466352
    [Abstract] [Full Text] [Related]

  • 20. Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man.
    Teng CM, Hsueh CM, Chang YL, Ko FN, Lee SS, Liu KC.
    J Pharm Pharmacol; 1997 Jul 27; 49(7):706-11. PubMed ID: 9255715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.